migraine

News

Lilly chases Amgen with migraine drug filing

Eli Lilly has filed its galcanezumab migraine drug with the FDA, as it looks to claim second place among a group of companies attempting to market a new class of therapies.

News

A sad young woman is sitting in her kitchen with a headache

Novartis/Amgen's migraine drug excites with phase 3 data

Erenumab under review in US and EU

News

Alder shares slump despite migraine success

Investors concerned over strong placebo effect

News

Novartis files migraine drug with EMA

Erenumab could be first new treatment in a decade.

News

Teva plans migraine drug filing later this year

Blockbuster hopeful could launch next year if approved.

News

AstraZeneca Amenities Building - Mississauga - Sept 2005
Non exclusive, unlimited time license for print & web to WZMH Architects

AZ sells migraine drug rights to Grunenthal for $300m

AZ says migraine outside its strategic focus.

Lilly chases Amgen with migraine drug filing

Novartis/Amgen's migraine drug excites with phase 3 data

Alder shares slump despite migraine success

Novartis files migraine drug with EMA

Teva plans migraine drug filing later this year

AZ sells migraine drug rights to Grunenthal for $300m

Senju launches first-in-class dry eye disease drug in Japan

Using AI-driven synthetic personas to take your insights fur...

migraine

Editor's Picks